HIV testing algorithm using fourth generation reagents reduces the false positive rate of screening tests

Abstract To analyze the false-positive results of HIV screening in a women’s and children’s specialized hospital and discuss the improved effect of the testing algorithm that retesting with two fourth-generation HIV assays to reduce false-positive results. We retrospectively analyzed 380,390 samples...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Gou, Zhengxiang Gao, Yifei Duan, Yu Wu, Leiwen Peng
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-97169-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187432156200960
author Yu Gou
Zhengxiang Gao
Yifei Duan
Yu Wu
Leiwen Peng
author_facet Yu Gou
Zhengxiang Gao
Yifei Duan
Yu Wu
Leiwen Peng
author_sort Yu Gou
collection DOAJ
description Abstract To analyze the false-positive results of HIV screening in a women’s and children’s specialized hospital and discuss the improved effect of the testing algorithm that retesting with two fourth-generation HIV assays to reduce false-positive results. We retrospectively analyzed 380,390 samples tested with Roche Elecsys® HIV combi PT assay from 2020 to 2023. The responsive samples were retested using the Determine HIV Early Detect assay (Abbott Diagnostic) and the Elecsys® HIV DUO assay (Roche Diagnostic). Finally, the supplemental tests were used to confirm whether the sample is true positive. Of the 380,390 samples, 555 were reactive with Roche Elecsys® HIV combi PT assay. After re-testing with the Determine HIV Early Detect assay and Elecsys® HIV DUO assay, the reactive sample was reduced to 256 cases, and finally 122 cases were confirmed as true positive by supplementary tests. The false positive rate was reduced from 0.11 to 0.04%. The median cut-off index (COI) of false positive samples was significantly lower than that of true positive samples. Pregnancy, tumor and infertility are the top three clinical diagnoses of false positive patients (19.92%, 15.23% and 13.67%, respectively). Retested with two different fourth-generation HIV assays can significantly reduce the false positive rate and improve the positive predictive value. False-positive samples still require longer follow-up to rule out HIV infection.
format Article
id doaj-art-2df2cb81268a4839a36f8cac29243d5a
institution OA Journals
issn 2045-2322
language English
publishDate 2025-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-2df2cb81268a4839a36f8cac29243d5a2025-08-20T02:16:06ZengNature PortfolioScientific Reports2045-23222025-04-011511610.1038/s41598-025-97169-yHIV testing algorithm using fourth generation reagents reduces the false positive rate of screening testsYu Gou0Zhengxiang Gao1Yifei Duan2Yu Wu3Leiwen Peng4Department of Laboratory Medicine, West China Second University Hospital, Sichuan UniversityDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan UniversityDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan UniversityDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan UniversityDepartment of Laboratory Medicine, West China Second University Hospital, Sichuan UniversityAbstract To analyze the false-positive results of HIV screening in a women’s and children’s specialized hospital and discuss the improved effect of the testing algorithm that retesting with two fourth-generation HIV assays to reduce false-positive results. We retrospectively analyzed 380,390 samples tested with Roche Elecsys® HIV combi PT assay from 2020 to 2023. The responsive samples were retested using the Determine HIV Early Detect assay (Abbott Diagnostic) and the Elecsys® HIV DUO assay (Roche Diagnostic). Finally, the supplemental tests were used to confirm whether the sample is true positive. Of the 380,390 samples, 555 were reactive with Roche Elecsys® HIV combi PT assay. After re-testing with the Determine HIV Early Detect assay and Elecsys® HIV DUO assay, the reactive sample was reduced to 256 cases, and finally 122 cases were confirmed as true positive by supplementary tests. The false positive rate was reduced from 0.11 to 0.04%. The median cut-off index (COI) of false positive samples was significantly lower than that of true positive samples. Pregnancy, tumor and infertility are the top three clinical diagnoses of false positive patients (19.92%, 15.23% and 13.67%, respectively). Retested with two different fourth-generation HIV assays can significantly reduce the false positive rate and improve the positive predictive value. False-positive samples still require longer follow-up to rule out HIV infection.https://doi.org/10.1038/s41598-025-97169-yHIVScreening testsFalse-positiveTesting algorithmElecsys® HIV DUO assay
spellingShingle Yu Gou
Zhengxiang Gao
Yifei Duan
Yu Wu
Leiwen Peng
HIV testing algorithm using fourth generation reagents reduces the false positive rate of screening tests
Scientific Reports
HIV
Screening tests
False-positive
Testing algorithm
Elecsys® HIV DUO assay
title HIV testing algorithm using fourth generation reagents reduces the false positive rate of screening tests
title_full HIV testing algorithm using fourth generation reagents reduces the false positive rate of screening tests
title_fullStr HIV testing algorithm using fourth generation reagents reduces the false positive rate of screening tests
title_full_unstemmed HIV testing algorithm using fourth generation reagents reduces the false positive rate of screening tests
title_short HIV testing algorithm using fourth generation reagents reduces the false positive rate of screening tests
title_sort hiv testing algorithm using fourth generation reagents reduces the false positive rate of screening tests
topic HIV
Screening tests
False-positive
Testing algorithm
Elecsys® HIV DUO assay
url https://doi.org/10.1038/s41598-025-97169-y
work_keys_str_mv AT yugou hivtestingalgorithmusingfourthgenerationreagentsreducesthefalsepositiverateofscreeningtests
AT zhengxianggao hivtestingalgorithmusingfourthgenerationreagentsreducesthefalsepositiverateofscreeningtests
AT yifeiduan hivtestingalgorithmusingfourthgenerationreagentsreducesthefalsepositiverateofscreeningtests
AT yuwu hivtestingalgorithmusingfourthgenerationreagentsreducesthefalsepositiverateofscreeningtests
AT leiwenpeng hivtestingalgorithmusingfourthgenerationreagentsreducesthefalsepositiverateofscreeningtests